Three Large-Cap Biotechs That Stand Out in an Uncertain Market
April 06, 2023
Singh, Hartaj
Alphabet and Netflix: Both Industry Leaders, Both Cheap
November 21, 2022
Bierig, Robert F.
Sizing Up Risk Across the Biotech Cap Spectrum
August 18, 2022
Singh, Hartaj
Midcap and Small-Cap Biopharma Opportunities a Better Way to Go in 2021
September 30, 2020
Singh, Hartaj
Pharma M&A Activity Expected to Return in 2021
September 21, 2020
Kedra, Kevin
The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj
Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj
Integrating a Top-Down View with a Bottom-Up Investment Approach
March 24, 2017
Snell, Patrick
Investing in Disruptive High-Growth Companies
April 08, 2016
Tubbs, Leslie
Looking for the World’s Best Companies with the Best Balance Sheets
November 06, 2015
Edgerton, Bobby
Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014
Biotech Space Concentrates on Gene Therapy, CAR T-Cell Technology Side
July 23, 2014
A Large-Cap Growth Strategy Focused on Capital Appreciation and Income
January 28, 2014
Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013
High Success Rates and Significant M&A in the Antibody Space
April 16, 2013
U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012
Nano Manufacturing Prospects In Semiconductors - Daniel Heyler - Bank Of America Merrill Lynch (asia Pacific) Ltd.
June 13, 2011
Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010
INVESTING IN DIABETES-RELATED STOCKS - DAVID A. KLIFF - DIABETIC INVESTOR
November 17, 2008
Roundtable Forum: Gaming
October 06, 2003
L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003
Ian Smith - Vertex Pharmaceuticals Inc (vrtx)
June 02, 2002
R.schwarzkopf / S.gleason - Kayne Anderson Rudnick Investment Mgmt Llc
February 25, 2002
R.crit Thomas - Armada Funds
February 04, 2002
Medical Device Companies / Small & Mid-cap: Charles Olsziewski - Ubs Warburg
October 12, 2001
Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001
Harry Penner Jr. - Neurogen Corporation (nrgn)
December 02, 1999
